{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:20:13Z","timestamp":1793330413298,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["JP 22K09271"],"award-info":[{"award-number":["JP 22K09271"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12975-025-01408-3","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:37:00Z","timestamp":1767922620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intravenous Human Umbilical Cord-Derived Mesenchymal Stromal Cells Promote Functional Recovery after Experimental Intracerebral Hemorrhage Via Local and Systemic Immunomodulation"],"prefix":"10.1007","volume":"17","author":[{"given":"Shoichiro","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Kuramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Doe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yamahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","volume":"373","author":"AI Qureshi","year":"2009","unstructured":"Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632\u201344.","journal-title":"Lancet"},{"key":"1408_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167\u201376.","journal-title":"Lancet Neurol"},{"key":"1408_CR3","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53:e282\u2013361.","journal-title":"Stroke"},{"key":"1408_CR4","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","volume":"1","author":"RV Krishnamurthi","year":"2013","unstructured":"Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990\u20132010: findings from the global burden of disease study 2010. Lancet Glob Health. 2013;1:e259\u201381.","journal-title":"Lancet Glob Health"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","volume":"365","author":"AD Mendelow","year":"2005","unstructured":"Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387\u201397.","journal-title":"Lancet"},{"key":"1408_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(11)60325-5","volume":"377","author":"P Langhorne","year":"2011","unstructured":"Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377:1693\u2013702.","journal-title":"Lancet"},{"key":"1408_CR7","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1161\/STROKEAHA.110.599654","volume":"42","author":"O Lindvall","year":"2011","unstructured":"Lindvall O, Kokaia Z. Stem cell research in stroke: how far from the clinic? How far from the clinic? Stroke. 2011;42:2369\u201375.","journal-title":"Stroke"},{"key":"1408_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nature04960","volume":"441","author":"O Lindvall","year":"2006","unstructured":"Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006;441:1094\u20136.","journal-title":"Nature"},{"key":"1408_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11\u201322.","journal-title":"Cell Stem Cell"},{"key":"1408_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","volume":"100","author":"IL Weissman","year":"2000","unstructured":"Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157\u201368.","journal-title":"Cell"},{"key":"1408_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"1408_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"1408_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kl\u00fcter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294\u2013301.","journal-title":"Stem Cells"},{"key":"1408_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439\u201341.","journal-title":"Lancet"},{"key":"1408_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579\u201386.","journal-title":"Lancet"},{"key":"1408_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874\u201382.","journal-title":"Ann Neurol"},{"key":"1408_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","volume":"92","author":"J Chen","year":"2003","unstructured":"Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692\u20139.","journal-title":"Circ Res"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt159","volume":"4","author":"M Guti\u00e9rrez-Fern\u00e1ndez","year":"2013","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez M, Rodr\u00edguez-Frutos B, Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerd\u00e1n S, et al. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 2013;4:11.","journal-title":"Stem Cell Res Ther"},{"key":"1408_CR19","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00264-014-2391-1","volume":"38","author":"P Hernigou","year":"2014","unstructured":"Hernigou P, Flouzat Lachaniette CH, Delambre J, Zilber S, Duffiet P, Chevallier N, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38:1811\u20138.","journal-title":"Int Orthop"},{"key":"1408_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211\u201328.","journal-title":"Tissue Eng"},{"key":"1408_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","volume":"22","author":"PS In \u2018t Anker","year":"2004","unstructured":"In \u2018t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GMJS, Claas FHJ, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338\u201345.","journal-title":"Stem Cells"},{"key":"1408_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/17460751.4.2.275","volume":"4","author":"O Parolini","year":"2009","unstructured":"Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med. 2009;4:275\u201391.","journal-title":"Regen Med"},{"key":"1408_CR23","doi-asserted-by":"publisher","first-page":"e88319","DOI":"10.1371\/journal.pone.0088319","volume":"9","author":"K Yamahara","year":"2014","unstructured":"Yamahara K, Harada K, Ohshima M, Ishikane S, Ohnishi S, Tsuda H, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS One. 2014;9:e88319.","journal-title":"PLoS One"},{"key":"1408_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-022-02411-3","volume":"19","author":"Y Kuramoto","year":"2022","unstructured":"Kuramoto Y, Fujita M, Takagi T, Takeda Y, Doe N, Yamahara K, et al. Early-phase administration of human amnion-derived stem cells ameliorates neurobehavioral deficits of intracerebral hemorrhage by suppressing local inflammation and apoptosis. J Neuroinflammation. 2022;19:48.","journal-title":"J Neuroinflammation"},{"key":"1408_CR25","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/s41598-021-81916-y","volume":"11","author":"Y Tago","year":"2021","unstructured":"Tago Y, Kobayashi C, Ogura M, Wada J, Yamaguchi S, Yamaguchi T, et al. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation. Sci Rep. 2021;11:2406.","journal-title":"Sci Rep"},{"key":"1408_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ten.tec.2010.0136","volume":"17","author":"S D\u00edaz-Prado","year":"2011","unstructured":"D\u00edaz-Prado S, Mui\u00f1os-L\u00f3pez E, Hermida-G\u00f3mez T, Rendal-V\u00e1zquez ME, Fuentes-Boquete I, de Toro FJ, et al. Isolation and characterization of mesenchymal stem cells from human amniotic membrane. Tissue Eng Part C Methods. 2011;17:49\u201359.","journal-title":"Tissue Eng Part C Methods"},{"key":"1408_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","volume":"28","author":"N Kim","year":"2013","unstructured":"Kim N, Cho S-G. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28:387\u2013402.","journal-title":"Korean J Intern Med"},{"key":"1408_CR28","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"H-S Wang","year":"2004","unstructured":"Wang H-S, Hung S-C, Peng S-T, Huang C-C, Wei H-M, Guo Y-J, et al. Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem Cells. 2004;22:1330\u20137.","journal-title":"Stem Cells"},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","volume":"25","author":"S Karahuseyinoglu","year":"2007","unstructured":"Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25:319\u201331.","journal-title":"Stem Cells"},{"key":"1408_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","volume":"26","author":"DL Troyer","year":"2008","unstructured":"Troyer DL, Weiss ML. Wharton\u2019s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26:591\u20139.","journal-title":"Stem Cells"},{"key":"1408_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/14653249.2012.658911","volume":"14","author":"A Kikuchi-Taura","year":"2012","unstructured":"Kikuchi-Taura A, Taguchi A, Kanda T, Inoue T, Kasahara Y, Hirose H, et al. Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. Cytotherapy. 2012;14:441\u201350.","journal-title":"Cytotherapy"},{"key":"1408_CR32","doi-asserted-by":"crossref","unstructured":"Krafft PR, Rolland WB, Duris K, Lekic T, Campbell A, Tang J et al. Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase. J Vis Exp. 2012;e4289.","DOI":"10.3791\/4289"},{"key":"1408_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainres.2018.12.042","volume":"1711","author":"Y Kuramoto","year":"2019","unstructured":"Kuramoto Y, Takagi T, Tatebayashi K, Beppu M, Doe N, Fujita M, et al. Intravenous administration of human adipose-derived stem cells ameliorates motor and cognitive function for intracerebral hemorrhage mouse model. Brain Res. 2019;1711:58\u201367.","journal-title":"Brain Res"},{"key":"1408_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2019.01.037","volume":"1712","author":"K Tatebayashi","year":"2019","unstructured":"Tatebayashi K, Takagi T, Fujita M, Doe N, Nakagomi T, Matsuyama T, et al. Adipose-derived stem cell therapy inhibits the deterioration of cerebral infarction by altering macrophage kinetics. Brain Res. 2019;1712:139\u201350.","journal-title":"Brain Res"},{"key":"1408_CR35","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229:327\u201336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1408_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainres.2006.12.035","volume":"1136","author":"JK Wasserman","year":"2007","unstructured":"Wasserman JK, Schlichter LC. Neuron death and inflammation in a rat model of intracerebral hemorrhage: effects of delayed minocycline treatment. Brain Res. 2007;1136:208\u201318.","journal-title":"Brain Res"},{"key":"1408_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-020-01853-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, et al. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2020;17:168.","journal-title":"J Neuroinflammation"},{"key":"1408_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-10-27","volume":"10","author":"H Fang","year":"2013","unstructured":"Fang H, Wang P-F, Zhou Y, Wang Y-C, Yang Q-W. Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation. 2013;10:27.","journal-title":"J Neuroinflammation"},{"key":"1408_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages. Blood. 2011;118:330\u20138.","journal-title":"Blood"},{"key":"1408_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"1408_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987\u201391.","journal-title":"Nat Neurosci"},{"key":"1408_CR42","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJM200105103441907","volume":"344","author":"AI Qureshi","year":"2001","unstructured":"Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450\u201360.","journal-title":"N Engl J Med"},{"key":"1408_CR43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","volume":"11","author":"RF Keep","year":"2012","unstructured":"Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720\u201331.","journal-title":"Lancet Neurol"},{"key":"1408_CR44","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/STROKEAHA.110.596718","volume":"42","author":"J Aronowski","year":"2011","unstructured":"Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury: secondary brain injury. Stroke. 2011;42:1781\u20136.","journal-title":"Stroke"},{"key":"1408_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1474-4422(05)70283-0","volume":"5","author":"G Xi","year":"2006","unstructured":"Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53\u201363.","journal-title":"Lancet Neurol"},{"key":"1408_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fncel.2014.00388","volume":"8","author":"E Mracsko","year":"2014","unstructured":"Mracsko E, Veltkamp R. Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci. 2014;8:388.","journal-title":"Front Cell Neurosci"},{"key":"1408_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.03.003","volume":"178","author":"H Zhu","year":"2019","unstructured":"Zhu H, Wang Z, Yu J, Yang X, He F, Liu Z, et al. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol. 2019;178:101610.","journal-title":"Prog Neurobiol"},{"key":"1408_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1510039","volume":"15","author":"J-J Ju","year":"2024","unstructured":"Ju J-J, Hang L-H. Neuroinflammation and iron metabolism after intracerebral hemorrhage: a glial cell perspective. Front Neurol. 2024;15:1510039.","journal-title":"Front Neurol"},{"key":"1408_CR49","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076\u201384.","journal-title":"J Cell Biochem"},{"key":"1408_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","volume":"37","author":"TM Bliss","year":"2010","unstructured":"Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis. 2010;37:275\u201383.","journal-title":"Neurobiol Dis"},{"key":"1408_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beha.2011.01.004","volume":"24","author":"A Uccelli","year":"2011","unstructured":"Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol. 2011;24:59\u201364.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1408_CR52","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ. Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2013current views. Stem Cells. 2007;25:2896\u2013902.","journal-title":"Stem Cells"},{"key":"1408_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5045\/br.2013.48.2.107","volume":"48","author":"MW Lee","year":"2013","unstructured":"Lee MW, Kim DS, Yoo KH, Kim HR, Jang IK, Lee JH, et al. Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions. Blood Res. 2013;48:107\u201314.","journal-title":"Blood Res"},{"key":"1408_CR54","doi-asserted-by":"publisher","first-page":"30121","DOI":"10.1038\/srep30121","volume":"6","author":"L Liu","year":"2016","unstructured":"Liu L, Song H, Duan H, Chai J, Yang J, Li X, et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling. Sci Rep. 2016;6:30121.","journal-title":"Sci Rep"},{"key":"1408_CR55","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.12659\/MSM.900512","volume":"22","author":"J Xie","year":"2016","unstructured":"Xie J, Wang B, Wang L, Dong F, Bai G, Liu Y. Intracerebral and intravenous transplantation represents a favorable approach for application of human umbilical cord mesenchymal stromal cells in intracerebral hemorrhage rats. Med Sci Monit. 2016;22:3552\u201361.","journal-title":"Med Sci Monit"},{"key":"1408_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1094925","volume":"13","author":"Y Mo","year":"2022","unstructured":"Mo Y, Chen K. Review: the role of HMGB1 in spinal cord injury. Front Immunol. 2022;13:1094925.","journal-title":"Front Immunol"},{"key":"1408_CR57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/scd.2019.0176","volume":"29","author":"TG Mello","year":"2020","unstructured":"Mello TG, Rosado-de-Castro PH, Campos RMP, Vasques JF, Rangel-Junior WS, de Mattos RS, et al. Intravenous human umbilical cord-derived mesenchymal stromal cell administration in models of moderate and severe intracerebral hemorrhage. Stem Cells Dev. 2020;29:586\u201398.","journal-title":"Stem Cells Dev"},{"key":"1408_CR58","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1111\/jcmm.16577","volume":"25","author":"H-K Yip","year":"2021","unstructured":"Yip H-K, Lin K-C, Sung P-H, Chiang JY, Yin T-C, Wu R-W, et al. Umbilical cord-derived MSC and hyperbaric oxygen therapy effectively protected the brain in rat after acute intracerebral haemorrhage. J Cell Mol Med. 2021;25:5640\u201354.","journal-title":"J Cell Mol Med"},{"key":"1408_CR59","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13287-020-02011-z","volume":"11","author":"Q Xie","year":"2020","unstructured":"Xie Q, Liu R, Jiang J, Peng J, Yang C, Zhang W, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res Ther. 2020;11:519.","journal-title":"Stem Cell Res Ther"},{"key":"1408_CR60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-018-1279-1","volume":"15","author":"R Li","year":"2018","unstructured":"Li R, Liu W, Yin J, Chen Y, Guo S, Fan H, et al. TSG-6 attenuates inflammation-induced brain injury via modulation of microglial polarization in SAH rats through the SOCS3\/STAT3 pathway. J Neuroinflammation. 2018;15:231.","journal-title":"J Neuroinflammation"},{"key":"1408_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021162","volume":"24","author":"D La Russa","year":"2023","unstructured":"La Russa D, Di Santo C, Lizasoain I, Moraga A, Bagetta G, Amantea D. Tumor necrosis factor (TNF)-\u03b1-stimulated gene 6 (TSG-6): a promising immunomodulatory target in acute neurodegenerative diseases. Int J Mol Sci. 2023;24:1162.","journal-title":"Int J Mol Sci"},{"key":"1408_CR62","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/ijmm.2013.1290","volume":"31","author":"X-J Bao","year":"2013","unstructured":"Bao X-J, Liu F-Y, Lu S, Han Q, Feng M, Wei J-J, et al. Transplantation of Flk-1\u2009+\u2009human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and anti-inflammatory and angiogenesis effects in an intracerebral hemorrhage rat model. Int J Mol Med. 2013;31:1087\u201396.","journal-title":"Int J Mol Med"},{"key":"1408_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.reth.2025.05.011","volume":"30","author":"Sdela Calle","year":"2025","unstructured":"Calle Sdela, Zurita M. Mesenchymal stem cell for hemorrhagic stroke: a clinical review. Regen Ther. 2025;30:173\u201381.","journal-title":"Regen Ther"},{"key":"1408_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02770-x","volume":"13","author":"M Wu","year":"2022","unstructured":"Wu M, Chen L, Qi Y, Ci H, Mou S, Yang J, et al. Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin \u03b21\/ERK1\/2\/HIF-1\u03b1\/VEGF-A signaling pathway for off-the-shelf breast tissue engineering. Stem Cell Res Ther. 2022;13:99.","journal-title":"Stem Cell Res Ther"},{"key":"1408_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12028-023-01897-w","volume":"41","author":"NC Durand","year":"2024","unstructured":"Durand NC, Kim HG, Patel VN, Turnbull MT, Siegel JL, Hodge DO, et al. Mesenchymal stem cell therapy in acute intracerebral hemorrhage: a dose-escalation safety and tolerability trial. Neurocrit Care. 2024;41:59\u201369.","journal-title":"Neurocrit Care"},{"key":"1408_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3390446","volume":"2024","author":"C Wang","year":"2024","unstructured":"Wang C, Yan B, Liao P, Chen F, Lei P. Meta-analysis of the therapeutic effects of stem cell-derived extracellular vesicles in rodent models of hemorrhagic stroke. Stem Cells Int. 2024;2024:3390446.","journal-title":"Stem Cells Int"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-025-01408-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:03:42Z","timestamp":1773068622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-025-01408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s12975-025-01408-3","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all women according to our institutional ethics committee (approval number 325).All experiments were approved and confirmed by the Ethics Review Board of Hyogo Medical University (Approval numbers: 21\u2009\u2212\u2009012 and 24\u2013047\u00a0A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}